Category
Cancer
Sub Category
Breast
Study Name
S1202: A Randomized Placebo-controlled Phase III Study of Duloxetine for treatment of Aromatase Inhibitor (A-1) Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance